 |
|
Prostate Cancer - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
6. Comparing Radiation Therapies for Prostate Cancer
(Posted: 06/26/2007) - In this trial, men with favorable-risk, localized prostate cancer will be randomly assigned to receive conventionally fractionated radiation therapy over the course of about eight weeks (41 daily treatments) or hypofractionated radiotherapy over a five-and-a-half week period (28 daily treatments).
7. Sorafenib for Metastatic Prostate Cancer
(Posted: 01/23/2007) - In this clinical trial, patients with metastatic, androgen-independent prostate cancer will be treated with sorafenib, a small-molecule inhibitor that blocks the activity of several cancer-related proteins.
8. Combination Therapy for High-Risk Prostate Cancer
(Posted: 12/05/2006) - In this trial, after initial radiation and hormone therapy, men with localized, high-risk, androgen-responsive prostate cancer will be treated with the drugs docetaxel and prednisone.
9. Prostate Cancer Vaccine Trial
(Posted: 10/03/2006) - In this clinical trial, researchers are testing a new type of vaccine therapy in patients with prostate cancer that has recurred locally or progressed following previous treatment.
10. Targeted Therapy for Metastatic Prostate Cancer
(Posted: 06/20/2006) - This trial is evaluating the addition of two targeted therapies, bevacizumab and thalidomide, to chemotherapy with docetaxel and prednisone for patients with androgen-independent, metastatic prostate cancer.
< Previous 1 2 3 4 Next >
|
|
|
